{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,14]],"date-time":"2026-03-14T02:26:46Z","timestamp":1773455206116,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"Sloan Partners LLP"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Syst Rev"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1186\/s13643-018-0682-0","type":"journal-article","created":{"date-parts":[[2018,1,24]],"date-time":"2018-01-24T19:43:10Z","timestamp":1516822990000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Treatment outcomes in patients with opioid use disorder initiated by prescription: a systematic review protocol"],"prefix":"10.1186","volume":"7","author":[{"given":"Nitika","family":"Sanger","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meha","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie","family":"Sanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamnah","family":"Shahid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bianca","family":"Bantoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.Constantine","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Russell","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5974-9361","authenticated-orcid":false,"given":"Zainab","family":"Samaan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,1,25]]},"reference":[{"key":"682_CR1","unstructured":"UNODC. World drug report 2015 [Internet], vol. 53: United Nations publication; 2015. p. 1689\u201399. Available from: https:\/\/www.unodc.org\/documents\/wdr2015\/World_Drug_Report_2015.pdf ."},{"key":"682_CR2","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association, 2013. Diagnostic and statistical manual of mental disorders (DSM-5\u00ae). American Psychiatric Pub. Washington, DC.","DOI":"10.1176\/appi.books.9780890425596"},{"issue":"2","key":"682_CR3","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1093\/jurban\/jti049","volume":"82","author":"B Fischer","year":"2005","unstructured":"Fischer B, Rehm J, Brissette S, Brochu S, Bruneau J, El-Guebaly N, et al. Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN study). J Urban Heal. 2005;82(2):250\u201366.","journal-title":"J Urban Heal"},{"issue":"2","key":"682_CR4","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1007\/BF02190738","volume":"245","author":"G Bertschy","year":"1995","unstructured":"Bertschy G. Methadone maintenance treatment: an update. Eur Arch Psychiatry Clin Neurosci. 1995;245(2):114\u201324.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"682_CR5","first-page":"1378","volume":"64","author":"RA Rudd","year":"2016","unstructured":"Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014. Centers Dis Control Prev MMWR. 2016;64:1378\u201382.","journal-title":"Centers Dis Control Prev MMWR"},{"issue":"9810","key":"682_CR6","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(11)61138-0","volume":"379","author":"L Degenhardt","year":"2012","unstructured":"Degenhardt L, Hall W. Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet. 2012;379(9810):55\u201370.","journal-title":"Lancet"},{"issue":"2","key":"682_CR7","doi-asserted-by":"publisher","first-page":"e54496","DOI":"10.1371\/journal.pone.0054496","volume":"8","author":"GJ Unick","year":"2013","unstructured":"Unick GJ, Rosenblum D, Mars S, Ciccarone D. Intertwined epidemics: national demographic trends in hospitalizations for heroin- and opioid-related overdoses, 1993\u20132009. PLoS One [Internet]. 2013;8(2):e54496. Available from: https:\/\/doi.org\/10.1371\/journal.pone.0054496","journal-title":"PLoS One [Internet]"},{"key":"682_CR8","doi-asserted-by":"crossref","unstructured":"Mattick RP, Breen C, Kimber J, Davoli M. Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. Cochrane Database Syst Rev. 2009;3:CD002209.","DOI":"10.1002\/14651858.CD002209.pub2"},{"issue":"1","key":"682_CR9","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13293-015-0038-6","volume":"6","author":"M Bawor","year":"2015","unstructured":"Bawor M, Dennis BB, Varenbut M, Daiter J, Marsh DC, Plater C, et al. Sex differences in substance use, health, and social functioning among opioid users receiving methadone treatment: a multicenter cohort study. Biol Sex Differ. 2015;6(1):21.","journal-title":"Biol Sex Differ"},{"key":"682_CR10","doi-asserted-by":"crossref","unstructured":"Zhong W, Maradit-Kremers H, Sauver JLS, Yawn BP, Ebbert JO, Roger VL, Jacobson DJ, McGree ME, Brue SM, Rocca WA. Age and sex patterns of drug prescribing in a defined American population. In Mayo Clinic Proceedings (Vol. 88, No. 7, pp. 697-707). Elsevier; 2013.","DOI":"10.1016\/j.mayocp.2013.04.021"},{"issue":"9","key":"682_CR11","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1111\/j.1526-4637.2012.01467.x","volume":"13","author":"BD Darnall","year":"2012","unstructured":"Darnall BD, Stacey BR, Chou R. Medical and psychological risks and consequences of long-term opioid therapy in women. Pain Med. 2012;13(9):1181\u2013211.","journal-title":"Pain Med"},{"issue":"4","key":"682_CR12","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1056\/NEJMra1604339","volume":"375","author":"MA Schuckit","year":"2016","unstructured":"Schuckit MA. Treatment of opioid-use disorders. N Engl J Med. 2016;375(4):357\u201368.","journal-title":"N Engl J Med"},{"issue":"6","key":"682_CR13","doi-asserted-by":"publisher","first-page":"909","DOI":"10.15288\/jsad.2015.76.909","volume":"76","author":"S Darke","year":"2015","unstructured":"Darke S, Marel C, Slade T, Ross J, Mills KL, Teesson M. Patterns and correlates of sustained heroin abstinence: findings from the 11-year follow-up of the Australian treatment outcome study. J Stud Alcohol Drugs. 2015;76(6):909\u201315.","journal-title":"J Stud Alcohol Drugs"},{"issue":"593","key":"682_CR14","doi-asserted-by":"publisher","first-page":"e772","DOI":"10.3399\/bjgp11X613106","volume":"61","author":"NMJ Wright","year":"2011","unstructured":"Wright NMJ, Sheard L, Adams CE, Rushforth BJ, Harrison W, Bound N, et al. Comparison of methadone and buprenorphine for opiate detoxification (LEEDS trial): a randomised controlled trial. Br J Gen Pr. 2011;61(593):e772\u201380.","journal-title":"Br J Gen Pr"},{"issue":"9","key":"682_CR15","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1111\/add.13020","volume":"110","author":"TW Park","year":"2015","unstructured":"Park TW, Cheng DM, Lloyd-Travaglini CA, Bernstein J, Palfai TP, Saitz R. Changes in health outcomes as a function of abstinence and reduction in illicit psychoactive drug use: a prospective study in primary care. Addiction. 2015;110(9):1476\u201383.","journal-title":"Addiction"},{"issue":"2","key":"682_CR16","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/BF03256276","volume":"12","author":"Y Li","year":"2008","unstructured":"Li Y, Kantelip J-P, Gerritsen-van Schieveen P, Davani S. Interindividual variability of methadone response. Mol Diagn Ther. 2008;12(2):109\u201324.","journal-title":"Mol Diagn Ther"},{"issue":"1","key":"682_CR17","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1213\/01.ane.0b013e31816ba437","volume":"107","author":"RW Hurley","year":"2008","unstructured":"Hurley RW, MCB A. Sex, gender, and pain: an overview of a complex field. Anesth Analg. 2008;107(1):309.","journal-title":"Anesth Analg"},{"issue":"1","key":"682_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1081\/JA-120027764","volume":"39","author":"L Simoni-Wastila","year":"2004","unstructured":"Simoni-Wastila L, Ritter G, Strickler G. Gender and other factors associated with the nonmedical use of abusable prescription drugs. Subst Use Misuse. 2004;39(1):1\u201323.","journal-title":"Subst Use Misuse"},{"issue":"4","key":"682_CR19","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s11606-007-0129-0","volume":"22","author":"BA Moore","year":"2007","unstructured":"Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O\u2019Connor PG, et al. Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients. J Gen Intern Med. 2007;22(4):527\u201330.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"682_CR20","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jsat.2011.12.009","volume":"43","author":"S Nielsen","year":"2012","unstructured":"Nielsen S, Hillhouse M, Mooney L, Fahey J, Ling W. Comparing buprenorphine induction experience with heroin and prescription opioid users. J Subst Abus Treat. 2012;43(3):285\u201390.","journal-title":"J Subst Abus Treat"},{"key":"682_CR21","first-page":"361","volume":"8","author":"B Setnik","year":"2015","unstructured":"Setnik B, Roland CL, Sommerville KW, Pixton GC, Berke R, Calkins A, et al. A multicenter, primary care-based, open-label study to identify behaviors related to prescription opioid misuse, abuse, and diversion in opioid-experienced patients with chronic moderate-to-severe pain. J Pain Res. 2015;8:361.","journal-title":"J Pain Res"},{"issue":"12","key":"682_CR22","doi-asserted-by":"publisher","first-page":"2677","DOI":"10.1016\/j.pain.2013.07.046","volume":"154","author":"J H\u00f8jsted","year":"2013","unstructured":"H\u00f8jsted J, Ekholm O, Kurita GP, Juel K, Sj\u00f8gren P. Addictive behaviors related to opioid use for chronic pain: a population-based study. Pain. 2013;154(12):2677\u201383.","journal-title":"Pain"},{"key":"682_CR23","first-page":"2239","volume":"10","author":"BB Dennis","year":"2014","unstructured":"Dennis BB, Samaan MC, Bawor M, Paul J, Plater C, Pare G, et al. Evaluation of clinical and inflammatory profile in opioid addiction patients with comorbid pain: results from a multicenter investigation. Neuropsychiatr Dis Treat. 2014;10:2239.","journal-title":"Neuropsychiatr Dis Treat"},{"key":"682_CR24","first-page":"177","volume":"2","author":"RG Orwin","year":"2009","unstructured":"Orwin RG, Vevea JL. Evaluating coding decisions. Handb Res Synth meta-analysis. 2009;2:177\u2013203.","journal-title":"Handb Res Synth meta-analysis"},{"issue":"7","key":"682_CR25","doi-asserted-by":"publisher","first-page":"e1000097","DOI":"10.1371\/journal.pmed.1000097","volume":"6","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med. 2009;6(7):e1000097.","journal-title":"PLoS Med"},{"key":"682_CR26","unstructured":"Wells GA, Shea B, O\u2019connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. 2009. Epub Available from URL http\/\/www ohri ca\/programs\/clinical_epidemiology\/oxford htm [cited 2009 Oct 19]. 2013;"},{"issue":"1","key":"682_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/2046-4053-3-45","volume":"3","author":"M Bawor","year":"2014","unstructured":"Bawor M, Dennis BB, Anglin R, Steiner M, Thabane L, Samaan Z. Sex differences in outcomes of methadone maintenance treatment for opioid addiction: a systematic review protocol. Syst Rev. 2014;3(1):45.","journal-title":"Syst Rev."},{"key":"682_CR28","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JPT Higgins","year":"2011","unstructured":"Higgins JPT, Altman DG, G\u00f8tzsche PC, J\u00fcni P, Moher D, Oxman AD, et al. The Cochrane Collaboration\u2019s tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"682_CR29","unstructured":"Higgins JPT, Green S. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration. 2011. Available from http:\/\/handbook.cochrane.org ."},{"issue":"4","key":"682_CR30","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.jclinepi.2010.09.011","volume":"64","author":"GH Guyatt","year":"2011","unstructured":"Guyatt GH, Oxman AD, Sch\u00fcnemann HJ, Tugwell P, Knottnerus A. GRADE guidelines: a new series of articles in the Journal of Clinical Epidemiology. J Clin Epidemiol. 2011;64(4):380\u20132.","journal-title":"J Clin Epidemiol"},{"issue":"1","key":"682_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2046-4053-4-1","volume":"4","author":"D Moher","year":"2015","unstructured":"Moher D, Shamseer L, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 2015;4(1):1.","journal-title":"Syst Rev"}],"container-title":["Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13643-018-0682-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T15:48:35Z","timestamp":1570636115000},"score":1,"resource":{"primary":{"URL":"https:\/\/systematicreviewsjournal.biomedcentral.com\/articles\/10.1186\/s13643-018-0682-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1,25]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["682"],"URL":"https:\/\/doi.org\/10.1186\/s13643-018-0682-0","relation":{},"ISSN":["2046-4053"],"issn-type":[{"value":"2046-4053","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,1,25]]},"assertion":[{"value":"12 May 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 January 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors consent and approve the manuscript for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"16"}}